Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
Thumbnail

Machine learning predicts drug cardiotoxicity

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Thumbnail

Indoor air filters associated with a significant decrease in systolic blood pressure

Ambient air pollution directly leads to poorer health outcomes, and even short-term exposure to fine particulate matter can increase a person’s risk of adverse cardiovascular events.

Welldoc receives additional FDA approval for digital diabetes solution

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

Thumbnail

Healthcare groups encourage black women to monitor, manage their blood pressure

Numerous healthcare organizations have joined forces to launch a new ad campaign focused on helping black women learn more about monitoring and managing their blood pressure.

Thumbnail

International Society of Hypertension updates global treatment guidelines

The guidelines were specifically designed so that they could apply to patients from any country or socioeconomic group.

Thumbnail

Modifying saturated fat intake helps decrease risk of cardiovascular events by 21%

Limiting saturated fat intake can decrease a person’s risk of adverse cardiovascular events by a significant margin, according to a new systematic review of 15 different studies.

Thumbnail

FDA recalls multiple lots of extended-release metformin due to contamination

The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.

Thumbnail

New drug combination could lead to the return of an old diabetes treatment

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

Displaying 529 - 536 of 1158

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.